ERBB2 and breast carcinoma: Breast cancer is a heterogeneous disease, which is illustrated by differential expression of estrogen receptor (ER) and progesterone receptor (PR), occasional prevalence of HER2 amplification, and differences in proliferation rate which together provide the basis for the classification of breast cancer in different subgroups.